PUTNAM INVESTMENTS LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
PUTNAM INVESTMENTS LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$3,162,000
+9.6%
56,513
+1.4%
0.01%
+20.0%
Q2 2022$2,884,000
-12.4%
55,718
+22.9%
0.01%0.0%
Q1 2022$3,294,000
-37.3%
45,333
+2.1%
0.01%
-28.6%
Q4 2021$5,252,000
+7.6%
44,418
+22.1%
0.01%
-12.5%
Q3 2021$4,880,000
-14.5%
36,373
+3.2%
0.01%
-11.1%
Q2 2021$5,706,00035,2460.01%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders